期刊
JOURNAL OF FUNGI
卷 8, 期 3, 页码 -出版社
MDPI
DOI: 10.3390/jof8030295
关键词
Aspergillus fumigatus; sulfur metabolism; antifungal targets
资金
- Atraccion de Talento Modalidad I, Comunidad de Madrid contract [2020-T1/BMD-20011]
Fungal infections pose an increasing threat to human health, and the limited availability of clinically approved antifungal agents, coupled with the rise of drug resistance, calls for the development of novel and efficient antifungals. This article summarizes the current knowledge of sulfur-related genes and pathways in Aspergillus fumigatus virulence, highlighting their potential as targets for drug development.
Fungal infections are a growing threat to human health. Despite their clinical relevance, there is a surprisingly limited availability of clinically approved antifungal agents, which is seriously aggravated by the recent appearance and fast spread of drug resistance. It is therefore clear that there is an urgent need for novel and efficient antifungals. In this context, metabolism is recognized as a promising source for new antifungal targets and, indeed, there are new drugs in development that target metabolic pathways. Fungal sulfur metabolism is particularly interesting, as many of its processes are essential for viability and/or pathogenicity and it shows substantial differences with human metabolism. This short-review will summarize our current knowledge of sulfur-related genes and routes that are important for Aspergillus fumigatus virulence, which consequently could be pursued for drug development.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据